287 related articles for article (PubMed ID: 5432194)
1. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
[No Abstract] [Full Text] [Related]
2. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
3. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
4. Bovine plasma thromboplastin antecedent (Factor XI) deficiency.
Kociba GJ; Ratnoff OD; Loeb WF; Wall RL; Heider LE
J Lab Clin Med; 1969 Jul; 74(1):37-41. PubMed ID: 5256172
[No Abstract] [Full Text] [Related]
5. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
6. Laboratory monitoring of oral anticoagulant therapy.
Poller L; Samama M
Clin Lab Med; 1994 Dec; 14(4):813-23. PubMed ID: 7874873
[TBL] [Abstract][Full Text] [Related]
7. Regional quality control of coagulation assay procedures (normotest, simplastin-a and thrombotest).
Kahan J
Thromb Diath Haemorrh; 1974 Sep; 32(1):79-89. PubMed ID: 4454048
[TBL] [Abstract][Full Text] [Related]
8. Progress in the control of oral anticoagulation.
Loeliger EA
Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
[No Abstract] [Full Text] [Related]
9. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
10. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
11. [Laboratory methods for the estimation of plasma clotting factors. Phase 2].
Kagami M
Rinsho Byori; 1969; 16():Suppl 16:85-92. PubMed ID: 5391589
[No Abstract] [Full Text] [Related]
12. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
13. Nephrotic syndrome. A hypercoagulable state.
Kendall AG; Lohmann RC; Dossetor JB
Arch Intern Med; 1971 Jun; 127(6):1021-7. PubMed ID: 5578557
[No Abstract] [Full Text] [Related]
14. Standardization of laboratory tests for controlling anticoagulent therapy.
Zucker S; Cathey MH; Sox PJ; Hall EC
Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
[No Abstract] [Full Text] [Related]
15. A circulating anticoagulant specific for factor V.
Handley DA; Duncan BM
Pathology; 1969 Oct; 1(4):265-72. PubMed ID: 5406477
[No Abstract] [Full Text] [Related]
16. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
Muntean W
Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
[TBL] [Abstract][Full Text] [Related]
17. [Electra 600 d : results of a three year study (author's transl)].
Gouault-Heilmann M; Dumont MD; Caron N; Guiard AM
Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):179-85. PubMed ID: 704333
[TBL] [Abstract][Full Text] [Related]
18. [Activity of coagulation factors II, V, VII and X in healthy dogs--dependence on age, sex and breed].
Mischke R
Berl Munch Tierarztl Wochenschr; 1994 Sep; 107(9):289-94. PubMed ID: 7980377
[TBL] [Abstract][Full Text] [Related]
19. [Blood coagulation factors during epidemic hepatitis in children].
Seiler G; Gröpl H
Arch Kinderheilkd; 1969 Jul; 179(2):164-71. PubMed ID: 5802842
[No Abstract] [Full Text] [Related]
20. Mechanism of action and monitoring of anticoagulants.
Hirsh J
Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
